Management of atopic dermatitis: nonadherence to topical therapies in treatment of skin disease and the use of calcineurin inhibitors in difficult eczema

Editorial

A Anstey. Br J Dermatol. 2009 Aug.

. 2009 Aug;161(2):219-20.

doi: 10.1111/j.1365-2133.2009.09218.x.

No abstract available

Comment on

Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N, Reitamo S, Dubertret L, Fekete GL, Kamoun MR, Lahfa M, Ortonne JP. Doss N, et al. Br J Dermatol. 2009 Aug;161(2):427-34. doi: 10.1111/j.1365-2133.2009.09143.x. Epub 2009 Apr 16. Br J Dermatol. 2009. PMID: 19416227 Clinical Trial.
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
Leung DY, Hanifin JM, Pariser DM, Barber KA, Langley RG, Schlievert PM, Abrams B, Hultsch T. Leung DY, et al. Br J Dermatol. 2009 Aug;161(2):435-43. doi: 10.1111/j.1365-2133.2009.09145.x. Epub 2009 Mar 30. Br J Dermatol. 2009. PMID: 19416245 Clinical Trial.
Adherence to topical dermatological therapy: lessons from oral drug treatment.
Gupta G, Mallefet P, Kress DW, Sergeant A. Gupta G, et al. Br J Dermatol. 2009 Aug;161(2):221-7. doi: 10.1111/j.1365-2133.2009.09253.x. Epub 2009 Apr 22. Br J Dermatol. 2009. PMID: 19548959 Review.